Search PubMed⌕ Search

Biomedical subjects

E Seidel

Publications and source records attributed to E Seidel.

44 records · Page 3Linked to original sources
PubMed1985

Persistence of Inoue-Melnick virus and antibody in cerebrospinal fluid.

Serial cerebrospinal fluid samples were obtained from 14 multiple sclerosis patients over a period of several months and were tested under code for Inoue-Melnick virus. In five of the positive patients, virus was present in 28 of 32 specimens collected over a period of 2 to 5 months. Four patients, from whom a total of 34 specimens were taken, yielded only a single isolate each. Five patients contributed 28 specimens, all of which were negative. In six patients (three virus positive and three virus negative), neutralizing antibody was detected in serum and in cerebrospinal fluid.

Adult↗
PubMed1985

Inhibitory effect of glucocorticoid hormones on the growth of Inoue-Melnick virus.

Glucocorticoid hormones inhibited the early stage of propagation of Inoue-Melnick virus in a dose-dependent manner in human diploid cell cultures. Prednisolone and hydrocortisone achieved complete inhibition of replication of the three Inoue-Melnick virus serotypes at concentrations of 0.2 X 10(-4) and 10(-5) M, respectively; strong inhibition was found even at 10(-5) and 10(-6) M, respectively. The steroid hormones did not show a direct effect on the virus.

Cell Line↗
PubMed1984

Characterization of IM virus, which is frequently isolated from cerebrospinal fluid of patients with multiple sclerosis and other chronic diseases of the central nervous system.

A transmissible agent, the IM virus, antigenically related to the Japanese subacute myelo-optico-neuropathy virus, has been isolated from several human cerebrospinal fluids obtained from American patients with multiple sclerosis and other chronic diseases of the central nervous system. The isolates were propagated in human diploid fibroblast (MRC5) cells, and virus was released into the culture medium in the absence of overt cytolysis. Infection of MRC5 cells resulted in a subtle alteration in the normal growth pattern of the cells. In unstained cultures, the cell changes were so mild that it was necessary to carry out all virus assays under code to eliminate bias. Cells in late passages were more susceptible than vigorously growing cells in early passages. Analysis of the kinetics of replication revealed that newly synthesized progeny virus was first detected about 12 h postinfection, that maximal virus release occurred by 48 h postinfection, and that virus production was persistent throughout an 8-day period. Several inhibitors of DNA synthesis were effective in blocking viral replication, including cytosine arabinoside, iododeoxyuridine, and phosphonoacetic acid. A substantial decrease in infectivity was observed upon treatment of IM virus with ether, suggesting that a lipid-containing structure is essential for infectivity. Ultrafiltration studies approximated the size (diameter) of IM virus to be between 100 and 200 nm.

Amyotrophic Lateral Sclerosis↗
PubMed1982

Isolation of virus from the spinal fluid of three patients with multiple sclerosis and one with amyotrophic lateral sclerosis.

A transmissible agent with the properties of a thermolabile filterable virus was isolated from the cerebrospinal fluid (CSF) of 4 Houston patients with chronic central nervous system (CNS) disease. 3 had multiple sclerosis and I had amyotrophic lateral sclerosis. No isolations were made from 27 patients whose CSF was taken for diagnosis of illness unrelated to degenerative CNS disease. Neutralising antibodies to the 4 isolates were present in the serum of each of the 4 patients with virus (14 positive results among 15 tests) but in hardly any of the sera from 8 patients without virus (3 antibody-positive results among 32 tests). The agent is antigenically related to the virus isolated in Japan from cases of subacute myelo-optico-neuropathy.

Adult↗
PubMed1977

[Studies of the time of effectiveness and the characterization of compounds in insecticide tests with Aedes aegypti].

The contact-toxicity of 5 insecticides (2 chlorinated hydrocarbons, 2 organophosphate compounds 1 P-substance) are tested against Aedes aegypti L (adults). Because of the relationship between dosage (quantity of application) and time of effectiveness of a compound, we are able to design a specific curve of time-efficacy of each insecticide at graded intervals (= increasing dilutions). This curve may be characteristic of different pure compounds--possibly in connection with other features. The time measurement as a quantitative response was chosen according to the directions of Finney 1952 (mean time to response--dosage). The simple statistical analysis was possible after continuous observation until response-metameter as criterion for time of bioassay = time of exposure. Transformation into complete records (Finney) in feasible with a long period of observation, corresponding response-metameter, extreme values etc. This was found to be the only way to obtain a statistical analysis without complications, and only a few parameters in this model. For statistical evaluation of the differences of the mean reaction times for each dilution of DDT, gamma-BHC, Methylparathion and Trichlorofon the U-test according to Mann & Whitney has been applied. Percentages of 'inactivity' at each dilution are added (decreasing from D7). --The curve of time--efficacy is described, and the possibilities of characterization and indentification of the compounds discussed. General features of ET 50 values and mean reaction times are pointed out, and also the relation of time to response (= exposure time) and dosage, expressed by a simple hyperbolic equation (Haber's formula). The uptake of insecticides by "self-dosine" of insects (as practised in this bioassay) is the closest approximation to natural conditions, but the real dose is unknown [and will depend on the physiological condition of the insects]. Some values with Aedes aegypti (whole activity of the pure compound of each test object labelled with radioactive Trichlorfon) are added (exposure on 1 per cent deposite of insecticide).

Aedes↗
PubMed1977

[Some considerations on the goals of rehabilitation - as seen from the viewpoint of social insurance agencies (author's transl)].

1. The final goal of rehabilitation is - according to & 39 cap. 3 BSHG (Federal Law on Social Assistance) - the integration of the disabled person into society. This goal is reached as soon as the disabled person has been resettled into employment and professional life through adequate measures and when it is possible for him/her to participate in community life. Through his resettlement into employment and professional life the disabled person's integration into society is thus achieved in part. 2. The responsibility for the various phases of the rehabilitation process is divided among different social security agencies. Comprehensive rehabilitation is guaranteed through the close cooperation between these agencies.

Adult↗